Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.

OBJECTIVES The new single-shot and interval treatment for Menière's disease with gentamicin was designed to avoid cochlear damage during treatment with gentamicin. METHODS To date, 90 patients were treated with the single-shot or interval gentamicin therapy. Fifty-seven cases of Menière's disease were followed up prospectively between 2 and 4 years… CONTINUE READING